HOME >> BIOLOGY >> NEWS
Max-Planck Researchers Unravel The Structure Of The Methane Forming Enzyme

Max-Planck researchers unravel the structure of the methane forming enzyme

A team of the Max-Planck Institutes from Frankfurt and Marburg has recently determined the structure of methyl-coenzyme M reductase, a key enzyme of methanogenesis that catalyzes a highly complex chemical reaction namely the reduction of a thioether to a hydrocarbon.

Methanogenesis is only carried out by a group of strictly anaerobic microbes called methanogens which use the formation of methane for the purpose of cellular energy generation. Within the microbial ecosystem methanogens participate in the final step of anoxic decomposition of complex organic materials thereby producing about 109 tons of methane per year. The generated methane is either remetabolized by methanotrophic bacteria or escapes to the atmosphere as a potent greenhouse gas. All methanogens are dependent on the enzyme methyl-CoM reductase, a protein complex of 300 kDa size. Its crystal structure was solved to a resolution of 1.45 E which represents the highest resolution for biological macromolecules of that size so far.

Nature has evolved with methyl-coenzyme M reductase a remarkable enzyme composed of six subunits forming a heterohexamer in an (a,_,c)2 arrangement. Three unusual coenzymes are embedded in a 30 E long channel between the subunits. Of particular interest is the binding of coenzyme F430, a Ni-porphinoid which exclusively occurs in this enzyme. As substrates the enzyme binds methyl-coenzyme M (methyl-thioethane sulfonate) and coenzyme B (7-thioheptanoyl threoninephosphate). The highly resolved crystal structure allows a description of the binding modes of these 3exotic2 coenzymes within the protein on an atomic ground.

The biochemical reaction of methyl-coenzyme M reductase proceeds by reducing of methyl-coenzyme M to methane and by oxidizi
'"/>

Contact: Ulrich Ermler
ermler@mpibp-frankfurt.mpg.de
+49-69-96769-384
Max-Planck-Gesellschaft
21-Nov-1997


Page: 1 2

Related biology news :

1. Max-Planck doctoral student discovers living fossils
2. Researchers determine genetic cause of Timothy syndrome
3. Researchers find color sensitive atomic switch in bacteria
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Researchers develop fast track way to discover how cells are regulated
9. Researchers identify distinctive signature for metastatic prostate cancer
10. Researchers report new gene test for isolated cleft lip and palate
11. Researchers discover why mutant gene causes colon cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells ... multiple areas of medicine, due to their differentiating characteristics. Stem cells are unique as ... ability to be induced to become tissue or organic-specific cells with special functions. ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017  OncoGenex ... apatorsen results from two randomized Phase 2 clinical trials were ... Genitourinary Cancers Symposium, held February 16 th - 18 th ... trials in bladder and prostate cancers demonstrated apatorsen was well-tolerated ... treatments. ...
(Date:2/21/2017)...   Invitae Corporation (NYSE: NVTA), one of ... members of the company,s management team will present at ... on Monday, March 6, 2017 at approximately 4:00 p.m. ... Massachusetts . The live, listen-only ... the investors section of the company,s website at ...
Breaking Biology Technology:
Cached News: